Phospholipase D gene originated from plant

TECHNICAL FIELD
The present invention relates to a phospholipase D gene originated from a plant.
BACKGROUND ART
Phospholipase D (hereinafter also referred to as "PLD") is one of phospholipid-decomposing enzymes, which catalyzes, for example, the reaction of decomposing lecithin to liberate phosphatidic acid and choline. This enzyme is known to occur in plants, animals and microorganisms. PLD is used as a reagent for measuring phospholipids in blood, as well as for hydrolysis of phospholipids and for production of derivatives by a base-exchange reaction utilizing the reversible reaction by PLD.
Purification and partial purification of PLDs originated from plants have been reported. That is, purification of rice PLD (Men Hui Lee, 1989, Phospholipase D of rice bran, I, purification and characterization, Plant Science 59, 25-33); partial purification of rice PLD (Katsumi TAKANO, Ikuzo KAMOI and Tetsujiro OBARA, 1987, About separation and purification, and properties of rice bran phospholipase D, J. Jpn. Soc. Food Sci. Technol., 34, 8-13 (1987)); purification of peanuts PLD (Michael Heller, Nava Mozes, Irena Peri and Eddie Maes, 1974, Phospholipase D from peanut seeds, IV, Final purification and some properties of the enzyme, Biochem. Biophys, Acta 369, 397-410); and purification of cabbage PLD (Romy Lambrecht and Renate Ulbrich-Hofmann, 1992, A facile purification procedure of phospholipase D from cabbage and its characterization, Biol. Chem. Hoppeseyler 373(2), 81-88) have been reported. However, amino acid sequences of plant PLDs have not been reported at all and genetical analyses thereof have also not been reported.
On the other hand, analyses of PLD genes of microorganisms and animals have been reported (Japanese Laid-open Patent Application (Kokai) No. 3-187382; Adrian L. M. Hodgson, Phillip Bird, and Ian T. Nisbet 1990, Cloning, nucleotide sequence, and expression in Escherichia coli of the phospholipase D gene from Corynebacterium pseudotuberculosis, Journal of Bacteriology 172, 1256-1261; and Japanese Laid-open Patent Application (Kokai) No. 5-76357).
If a PLD gene originated from a plant were available, the PLD originated from the plant may be produced in a large scale by a genetic engineering process, which is industrially advantageous. However, as mentioned above, since the amino acid sequence and DNA sequence of plant PLD have not been reported, it has hitherto been impossible to genetically manipulate the PLD gene. Further, as mentioned above, although the amino acid sequences and DNA sequences of PLDs of microorganisms and animals have been reported, since homologies of sequences are not observed among the PLD genes of microorganisms or among the PLD genes of microorganisms and animals, it is difficult to isolate plant PLD gene based on the reported information. Further, since there is no information about plant PLD gene, an antisense DNA which suppresses expression of the plant PLD gene has not been obtained.
DISCLOSURE OF THE INVENTION
An object of the present invention is to provide a PLD gene originated from a plant. Another object of the present invention is to provide an antisense DNA which can suppress the expression of the above-mentioned PLD gene according to the present invention. Still another object of the present invention is to provide a DNA which regulates expression of the PLD gene originated from a plant.
After intensive study, the present inventors succeeded in isolation of rice PLD gene and in sequencing the PLD gene by purifying PLD from rice, determining the partial amino acid sequence thereof, screening a rice cDNA library using as a probe the PCR product obtained by using the oligonucleotides encoding the above-mentioned partial amino acid sequence, cloning the inserted gene of positive clones and sequencing the inserted gene. Further, the present inventors succeeded in obtaining a cDNA clone of maize PLD using as a probe the DNA encoding rice PLD, and in sequencing the maize PLD gene. The present inventors still further succeeded in isolating a genome DNA clone carrying the regulatory sequence of rice PLD gene and in sequencing it.
That is, the present invention provides a DNA encoding phospholipase D originated from a plant. The present invention also provides a DNA which regulates the expression of phospholipase D gene originated from a plant.
By the present invention, a PLD gene originated from a plant was cloned for the first time. By using the DNA according to the present invention, the PLD originated from a plant, which is industrially useful, can be produced in a large scale by a genetic engineering process. Further, by the present invention, a DNA which regulates expression of the PLD gene originated from a plant was cloned for the first time. By virtue of this, expression of lipid-related genes may be suppressed, thereby modifying plant lipids.
BEST MODE FOR CARRYING OUT THE INVENTION
As mentioned above, the DNA according to the present invention encodes PLD originated from a plant. In the examples hereinbelow described, the DNA encoding rice PLD was isolated and sequenced. The deduced amino acid sequence encoded by the thus sequenced DNA is shown in SEQ ID NO. 2 in the Sequence Listing. The experimentally determined nucleotide sequence encoding the amino acid sequence shown in SEQ ID NO. 2 is shown in SEQ ID NO. 1. Therefore, the amino acid sequence shown in SEQ ID NO. 1 is identical to the amino acid sequence shown in SEQ ID NO. 2. Further, in the examples hereinbelow described, a cDNA clone of maize PLD gene was isolated using as a probe the thus sequenced DNA encoding the rice PLD and the maize PLD gene was sequenced. The deduced amino acid sequence encoded by the thus sequenced DNA is shown in SEQ ID NO. 4 in the Sequence Listing. The experimentally determined nucleotide sequence encoding the amino acid sequence shown in SEQ ID NO. 4 is shown in SEQ ID NO. 3. Therefore, the amino acid sequence shown in SEQ ID NO. 3 is identical to the amino acid sequence shown in SEQ ID NO. 4.
Further, in the examples described below, rice cDNA library was screened using as a probe the thus obtained DNA encoding rice PLD and positive clones were isolated, followed by sequencing the inserted DNA to obtain a clone carrying an inserted DNA having the nucleotide sequence shown in SEQ ID NO. 5. In SEQ ID NO. 5, the 1876th base is "A" which is the first "A" in the translation initiation codon ATG of the PLD structural gene, and the region upstream of the "A" (i.e., 1-1875nt) is thought to be a regulatory region of the PLD gene. The amino acid sequence encoded by the region downstream of 1876nt is interrupted by introns.
The DNA according to the present invention may be obtained by, for example, the method described in the examples below in which rice or maize is used as the starting material. Alternatively, since the nucleotide sequence of the gene was disclosed by the present invention, the PLD gene may easily be prepared by PCR method using as primers a pair of oligonucleotides each of which hybridizes with the respective end of the DNA according to the present invention and using the genome DNA of rice or maize as a template.
A plant producing PLD may be obtained by inserting the DNA encoding PLD originated from a plant according to the present invention into a vector for plants by a conventional method and transforming a plant with the obtained recombinant vector by a conventional method.
By inserting the DNA according to the present invention into a vector for plants in the reverse direction, an antisense DNA of PLD gene may be obtained. By transforming a plant with such a recombinant vector, the mRNA which hybridizes with the mRNA formed by transcription of the PLD gene intrinsic to the plant is produced, so that expression of the PLD gene intrinsic to the plant may be suppressed. If this technique is applied to a rice plant, a rice plant in which expression of PLD gene is suppressed is obtained, so that the taste of the rice is improved.
The DNA regulating the PLD gene originated from a plant according to the present invention may be used in combination with the antisense DNA of the PLD gene. By this, the antisense DNA can be expressed at the same place as the place in which the PLD gene intrinsic to the plant is expressed.
It is well-known in the art that there are cases wherein the activity of an enzyme is retained even if the amino acid sequence of an enzyme is modified to a small extent, that is, even if one or more amino acids in the amino acid sequence are substituted or deleted, or even if one or more amino acids are added to the amino acid sequence. DNAs encoding the proteins having such modifications and having PLD activity are included within the scope of the present invention. That is, cloned DNAs encoding amino acid sequences having the same amino acid sequence as SEQ ID NO. 2 or SEQ ID NO. 4 except that one or more amino acids are substituted, deleted or added, which give the enzyme activity of PLD, are also included in the scope of the present invention. Similarly, DNAs having the same nucleotide sequence as SEQ ID NO. 5 except that one or more nucleotides are substituted, deleted or added, which regulate expression of the DNA encoding the amino acid sequence giving the enzyme activity of PLD are also included within the scope of the present invention.
Modification of DNA which brings about addition, deletion or substitution of the amino acid sequence encoded thereby can be attained by the site-specific mutagenesis which is well-known in the art (e.g., Nucleic Acid Research, Vol. 10, No. 20, p6487-6500, 1982). In the present specification, "one or more amino acids" means the number of amino acids which can be added, deleted or substituted by the site-specific mutagenesis.
Site-specific mutagenesis may be carried out by, for example, using a synthetic oligonucleotide primer complementary to a single-stranded phage DNA except that the desired mutation as follows. That is, using the above-mentioned synthetic oligonucleotide as a primer, a complementary chain is produced by a phage, and host bacterial cells are transformed with the obtained double-stranded DNA. The culture of the transformed bacterial cells is plated on agar and plaques are formed from a single cell containing the phage. Theoretically, 50% of the new colonies contain the phage having a single-stranded chain carrying the mutation and remaining 50% of the colonies contain the phage having the original sequence. The obtained plaques are then subjected to hybridization with a kinase-treated synthetic probe at a temperature at which the probe is hybridized with the DNA having exactly the same sequence as the DNA having the desired mutation but not with the original DNA sequence that is not completely complementary with the probe. Then the plaques in which the hybridization was observed are picked up, cultured and the DNA is collected.
In addition to the above-mentioned site-specific mutagenesis, the methods for substituting, deleting or adding one or more amino acids without losing the enzyme activity include a method in which the gene is treated with a mutagen and a method in which the gene is selectively cleaved, a selected nucleotide is removed, added or substituted and then the gene is ligated.

EXAMPLES
The present invention will now be described more concretely by way of examples. However, the present invention is not restricted to the examples described below.
1. Purification of rice bran PLD
For the purification, a reference relating to the purification of rice bran PLD (Takano et al., J. Jpn. Soc. Food Sci. Technol., 34, 8-13 (1987)) was referred. The enzyme activity was measured by using phosphatidylcholine as the substrate and by quantifying the choline generated by the enzyme reaction by the choline oxidase method (Imamura et al., J. Biochem. 83, 677-680 (1978)). The enzyme reaction, however, was stopped by heat treatment at 95.degree. C. for 5 minutes.
That is, one liter of hexane was added to 100 g of rice bran of Oryza sativa variety "Koshihikari" and the mixture was stirred overnight to defat the rice bran. Then 10 g of POLYCRAL AT (trademark: polyvinylpyrrolidone commercially available from GAF Chemical) and 500 ml of 10 mM Tris-HCl buffer (pH 7) containing 1 mM CaCl.sub.2 and 5 mM 2-mercaptoethanol were added and the resulting mixture was stirred for one hour to extract enzyme. The extract was filtered through 8-ply gauze and the filtrate was centrifuged at 15,000.times.g for 20 minutes. The intermediate layer was collected as a crude extract. The crude extract was treated with ammonium sulfate (65% saturation) and formed precipitates were collected by centrifugation (15,000.times.g, 20 minutes). The precipitates were dissolved and dialyzed against the above-described buffer. After the dialysis, precipitates were removed by centrifugation to obtain a ammonium sulfate fraction.
The ammonium sulfate fraction was applied to a DEAE-Cellulose (commercially available from Whattman) column (2.0.times.10 cm) equilibrated with buffer A (10 mM Tris-HCl pH 7, 1 mM CaCl.sub.2, 1 mM 2-mercaptoethanol). After washing the column with about 100 ml of buffer A containing 50 mM having linear gradient of NaCl from 50 to 350 mM. PLD was eluted in the vicinity of 0.2M of NaCl. The fractions exhibiting PLD activity were collected as an eluted solution (DEAE-Cellulose).
To the eluted solution (DEAE-Cellulose), 3M of ammonium sulfate was added to a concentration of 1M and the resultant was applied to a Phenyl Sepharose column (commercially available from PHARMACIA, 2.6.times.10 cm). Then the column was subjected to elution with 240 ml of buffer A having a gradient of ammonium sulfate from 1.0 to 0M. PLD was eluted in the vicinity of 0.1M of ammonium sulfate. Fractions exhibiting PLD activity were collected and dialyzed against buffer A to obtain an eluted solution (Phenyl Sepharose).
The eluted solution (Phenyl Sepharose) was applied to a Mono Q column (anion-exchange column, commercially available from PHARMACIA, 16.times.10 cm) and then elution was carried out with 150 ml of buffer A having a gradient of NaCl from 50-350 mM. PLD was eluted at NaCl concentrations from 210 mM to 235 mM. The fractions exhibiting PLD activity were collected and dialyzed against buffer A to obtain an eluted solution (Mono Q 1st).
The eluted solution (Mono Q 1st) was concentrated to 0.5 ml by centrifugal ultrafiltration and the resultant was applied to Superose 6 column (commercially available from PHARMACIA, 1.0-30 cm) equilibrated with buffer A containing 0.1M NaCl, and the column was subjected to elution with the same buffer. The molecular weight of the PLD was estimated as 78 kDa. The fractions exhibiting PLD activity were collected as an eluted solution (Superose 6).
To the eluted solution (Superose 6), 2.5 ml of 40% CARRIER AMPHOLITE (commercially available from PHARMACIA, pH 4.0-6.0) and distilled water were added to a final volume of 50 ml. The resultant was then subjected to isoelectric focusing using Rotofore (commercially available from BIORAD). The electrophoresis was carried out at 2.degree. C. under a constant power of 12W for 4 hours. PLD activity was observed in the vicinity of pH4.9. The fractions exhibiting PLD activity were collected and the obtained solution was dialyzed against buffer A to obtain an isoelectric focusing fraction.
The isoelectric focusing fraction was applied to a Mono Q column (commercially available from PHARMACIA, 0.5.times.5 cm) and elution was carried out using buffer A having a linear gradient of NaCl from 50 mM to 350 mM. PLD was eluted in the vicinity of 210 mM and 235 mM NaCl. The two fractions exhibiting PLD activity were collected as eluted solutions (Mono Q 2nd-I and Mono Q 2nd-II).
Purities of the eluted solutions (Mono Q 2nd-I and Mono Q 2nd-II) were determined by SDS-polyacrylamide gel electrophoresis (Laemmli (1970)). After the electrophoresis, the gels were stained with COOMASSIE BRILLIANT BLUE R250. With either eluted solution, a main band was observed at the position of molecular weight of 82 kDa. A single band was observed with eluted solution (Mono Q 2nd-II).
By the above-described purification, eluted solutions (Mono Q 2nd-I and Mono Q 2nd-II) were 380-fold and 760-fold purified, respectively, based on the crude extract.
The two fractions were analyzed for properties of the enzymes contained therein. The results are shown in Table 1. The buffer solutions used for measuring the optimum pH were sodium acetate (pH4-6), MES-NaOH (pH5.5-7.0) and Tris-HCl (pH7-9), all of which had a concentration of 100 mM. The pH stability means the range in which decrease in activity was not observed after leaving the enzyme to stand at 25.degree. C. for 30 minutes. The temperature stability was measured by measuring remaining activity after leaving the enzyme to stand at 4.degree. C., 25.degree. C., 37.degree. C. or 50.degree. C. for 30 minutes. The substrate specificity was measured at a substrate concentration of 5 mM and is expressed as a relative activity taking the enzyme activity to phosphatidylcholine as 100.
TABLE 1______________________________________ Mono Q 2nd-I Mono Q 2nd-II______________________________________Km Value 0.29 mM 0.29 mMOptimum pH 6 6pH Stability 7-8 7-8Temperature Stability 4-37.degree. C. 4-37.degree. C.Ca.sup.2+ Dependency 20 mM or more 20 mM or moreSubstrate SpecificityPhosphatidylcholine 100 100Lysophosphatidylcholine 13 12Sphingomyelin 6 4______________________________________
2. Proof that Purified Protein is PLD
In the same manner as in the determination of the purity, eluted solutions (Mono Q 2nd-I and Mono Q 2nd-II) were separately subjected to SDS-polyacrylamide gel electrophoresis and each of the gels was transcribed to a PVDF membrane (commercially available from MILLIPORE), followed by staining the membrane. The band corresponding to the protein having a molecular weight of 82 kDa was cut out and amino acid sequence of the N-terminal region of the protein was determined. Amino acid sequence up to 10th amino acid residue was able to be determined for both proteins, and both proteins had the same sequence as follows:
Val Gly Lys Gly Ala Thr Lys Val Tyr Ser
Although the relationship between the proteins of 82 kDa which existed in two fractions having the enzyme activity was unknown, at least the homology of the amino acid sequences thereof was thought to be high. Thus, it was thought that there was no problem even if a mixture of these fractions was used as an antigen for producing an antibody.
A mixture of the eluted solutions (Mono Q 2nd-I and Mono Q 2nd-II) was subjected to SDS-polyacrylamide gel electrophoresis employing 7.5% acrylamide and the gel was stained with COOMASSIE BRILLIANT BLUE R250. The band containing the protein of 82 kDa was cut out and the proteins were recovered by electroelution (25 mM Tris, 192 mM glycine, 0.025% SDS, 100V, 10 hours). After removing SDS by electrodialysis (15 mM ammonium bicarbonate, 200V, 5 hours), the resultant was freeze-dried. The electroelution and electrophoresis were performed by using BIOTRAP (commercially available from SCHLEICHER & SCHUELL).
Rabbits were immunized with the protein of 82 kDa highly purified by the above-described method. Immunization was performed by administering 50 .mu.g of the protein per time at 7 days' interval. Using blood serum before the immunization and after the third immunization, immunotitration was performed. That is, PLD solution containing 8.6.times.10.sup.-3 units of the enzyme, 0 to 50 .mu.l of the serum before the immunization or after the third immunization, 50 .mu.l of 250 mM Tris-HCl (pH 7.0), 5 .mu.l of 50 mM CaCl.sub.2, 50 .mu.l of 0.2% TRITON X-100 (trademark) and balance of water were mixed to a final volume of 250 .mu.l and the mixture was left to stand at room temperature for 2.5 hours. To the resulting mixture, 200 .mu.l of Protein A SEPHAROSE (commercially available from PHARMACIA) was added and the resultant was gently shaken at room temperature for 2 hours. The resultant was centrifuged (500.times.g, 5 minutes) and enzyme activity of the supernatant was measured. Taking the enzyme activity when no serum was added as 100%, the enzyme activities measured when 20 .mu.l or 50 .mu.l of the serum before the immunization were 95% and 88%, respectively, while the enzyme activities measured when 20 .mu.l or 50 .mu.l of the serum after the third immunization were 75% and 30%, respectively. These results proved that the protein of 82 kDa is PLD.
3. Determination of Internal Amino Acid Sequence
The PLD protein was fragmented by fragmenting the protein in a gel (Cleveland et al., J. Biol. Chem., 252, 1102(1977)). The gel containing the PLD protein, which was cut out by the same method as described in 2 was inserted in a stacking gel well on a 15% acrylamide gel prepared for separation of peptides. Staphylococcus aureus V8 protease (commercially available from WAKO PURE CHEMICAL INDUSTRIES, LTD) in an amount of 1/10 of the PLD protein was overlaid and electrophoresis was started. The electrophoresis was interrupted when bromophenol blue reached the center of the stacking gel, and 30 minutes after, the electrophoresis was restarted. After the electrophoresis, the gel was transcribed to a PVDF membrane and the PVDF membrane was stained. Clear bands were observed at positions corresponding to molecular weights of 20, 14, 13, 11 and 10 kDa. The bands corresponding to molecular weights of 20, 14 and 13 kDa were cut out and amino acid sequences of the peptide fragments contained in the bands were determined by a protein sequencer. The sequences are as follows:
20 kDa: Asn Tyr Phe His Gly Ser Asp Val Asn ? Val Leu
? Pro Arg Asn Pro Asp Asp(Asp) ? ? Ile
14 kDa: Thr ? Asn Val Gln Leu Phe Arg Ser Ile Asp Gly
Gly Ala Ala Phe Gly Phe Pro Asp Thr Pro Glu Glu Ala Ala
Lys ? Gly Leu Val Ser Gly
13 kDa: Ile Ala Met Gly Gly Tyr Gln Phe Tyr His Leu Ala Thr Arg Gln Pro Ala Arg Gly Gln Ile His Gly Phe Arg Met Ala Leu ? Tyr Glu His Leu Gly Met Leu ? Asp Val Phe
(In the sequences, "?" means the residue which could not be identified and the amino acid residue in parenthesis is one which may be another amino acid residue with a considerable probability.)
4. Preparation of cDNA Library of Rice Immature Seeds Total RNAs were prepared from immature seeds 5 days after blossom by extracting RNAs by the SDS-phenol method and by precipitating the extract with lithium chloride. Poly(A) +RNAs were prepared using OLIGOTEX-dT30 (commercially available from TAKARA SHUZO) in accordance with the instructions by the manufacturer. For cDNA cloning, cDNA SYNTHESIS SYSTEM PLUS (commercially available from AMERSHAM) and cDNA CLONING SYSTEM .lambda.gt10 (commercially available from AMERSHAM) were used. As the cloning vector, .lambda.ZAPII vector (commercially available from STRATAGENE) was used and as the host cells, XL1-Blue was used.
5. Preparation of Probes
Oligonucleotides corresponding to the amino acid sequence of PLD were synthesized by a DNA synthesizer (commercially available from APPLIED BIOSYSTEMS). The sequences thereof and the amino acid sequences corresponding thereto are described below.
20KF: 5'AAYTAYTTYCAYGG 3'
20KRI: 5'RTCRTCRTCNGGRTT 3'
(wherein R represents purine bases, that is, A or G; Y represents pyrimidine bases, that is, T or C; and N represents G, A, T or C.)
20KF is a mixture of 32 types of oligonucleotides each of which encodes the amino acid sequence of
Asn Tyr Phe His Gly
that was found in the peptide having a molecular weight of 20 kDa, and 20KR1 is a mixture of 128 types of oligonucleotides each of which encodes the amino acid sequence of
Asn Pro Asp Asp (Asp)
that was found in the same peptide.
The cDNA synthesis reaction was carried out in a mixture of 10 ng of Poly(A)+RNA, 0.3 .mu.g of random hexamer (dN6), 10 U of RNase inhibitor (RNAGuard, commercially available from PHARMACIA), 1 mM each of dATP, dCTP, dGTP and dTTP, 1.times.PCR buffer (commercially available from TAKARA SHUZO), 50 mM of magnesium chloride and 100 U of reverse transcriptase (M-MuLV RTase, commercially available from BRL), the total volume of the reaction mixture being 10 .mu.l. The reaction was carried out at 37.degree. C. for 30 minutes and the mixture was then heated at 95.degree. C. for 5 minutes, followed by retaining the resulting mixture in ice.
Polymerase chain reaction (PCR) was performed using the above-described cDNA as a template, and 20KF and 20KR1 as primers. The reaction was carried out using 10 .mu.l of the cDNA synthesis reaction mixture, a mixture of 50 pmol each of the primers, 200 .mu.M each of dATP, dCTP, dGTP and dTTP, 1.times.PCR buffer (commercially available from TAKARA SHUZO) and 2.5 U of AmpliTaq DNA polymerase (commercially available from TAKARA SHUZO), the total volume of the reaction mixture being 50 .mu.l. A cycle of 94.degree. C. for 1 minute/40.degree. C. for 1 minute/72.degree. C. for 2.5 minutes was repeated 30 times in DNA THERMOCYCLER (commercially available from PERKIN ELMER CETUS).
PCR product was separated on 2% agarose gel. Several fragments were detected by staining the gel with ethidium bromide. One of them had a size of 94 bp which is the expected size.
The PCR fragment was cut out from the gel and subcloned into pUC19 plasmid. The subcloned PCR fragment was sequenced by the dideoxy method using T7 sequencing kit (commercially available from PHARMACIA). Between the two primers, a nucleotide sequence encoding the expected amino acid sequence was observed. The nucleotide sequence between the two primers and the amino acid sequence encoded thereby are as follows:
C TCT GAC GTG AAC TGT GTT CTA TGC CCT CGC
Ser Asp Val Asn Cys Val Leu Cys Pro Arg
Isotope .sup.32 P (commercially available from AMERSHAM) was incorporated into the above-described oligonucleotide using DNA 5'-end labelling kit MEGALABEL (commercially available from TAKARA SHUZO) to obtain a radioactive oligonucleotide probe.
6. Screening of PLD Gene-containing Clone
Using the above-described radioactive oligonucleotide as a probe, a cDNA library was screened. The hybridization solution was 0.5M sodium phosphate buffer (pH 7.2) containing 7% SDS, 1 mM EDTA and 100 .mu.g/ml of salmon sperm DNA, and hybridization was carried out at 45.degree. C. for 16 hours after adding the probe to this solution. The washing solution contained 0.3M NaCl and 30 mM sodium citrate and washing was performed twice at 45.degree. C. for 20 minutes. Positive plaques were isolated and subcloned in vivo into pBluescript plasmid (commercially available from STRATAGENE) in accordance with the instruction of the manufacturer of .lambda.ZAPII cloning vector. The nucleotide sequence was determined and the region encoding the internal amino acid sequence determined in 3 existed.
7. Sequencing of 5'-end Region
Since a clone containing the full-length cDNA could not be isolated, a DNA fragment containing the 5'-end region was prepared by RACE method (Edwards et al., Nucleic Acids Res., 19, 5227-5232(1991)). 5'-AmpliFINDER RACE Kit (commercially available from CLONETECH) was used in accordance with the instructions attached to the product. OligoDNAs were prepared and PCR was performed using the mRNA prepared by the method described in 4 as a template. The PCR product was subcloned into PCRII vector (commercially available from INVITROGEN) and sequenced by the dideoxy method. As a result, it was estimated that translation is initiated from the 182th nucleotide shown in SEQ ID NO. 1 because a termination codon exists upstream thereof by 36 bp.
8. Preparation of cDNA Clone Encoding PLD Originated from Maize
Maize cDNA clone was obtained by the method described below using the DNA encoding rice PLD as a probe.
Using suspended cultured cells established by culturing a callus derived from immature embryo of maize inbred Mo 17(commercially available from MIKE BRAYTON SEEDS, INC.) in a liquid culture medium, a cDNA library was prepared by the method described in 4. However, .lambda.gt10 vector (commercially available from AMERSHAM) was used as the cloning vector and NM-514 (commercially available from AMERSHAM) was used as the host cells. Using the cDNA of rice PLD as a probe, positive plaques were isolated by the method described in 6. Phage DNA was prepared in accordance with the instructions by the manufacturer of the cloning vector. The phage DNA was digested with a restriction enzyme Kpn I and the resultant was subcloned into pBluescript plasmid. The nucleotide sequence was determined by the dideoxy method as described in 6.
9. Isolation of PLD Genome Clone Corresponding to PLD cDNA and Identification of Promoter Region
To isolate a genomic DNA clone carrying the regulatory sequence of the PLD gene corresponding to the PLD cDNA sequenced in 6, which was cloned into pBluescript plasmid, a genomic library of rice Koshihikari was prepared. This was carried out by partially digesting DNAs from leaves of Koshihikari with Mbo I, purifying fractions having sizes of 16-20 kb by sucrose gradient centrifugation, and by using lambda DASH II (commercially available from STRATAGENE) and GigapackII Gold (commercially available from STRATAGENE). Using the PLD cDNA clone as a probe, the genome library was screened. The screening was performed as described in 6. However, the hybridization was performed at 65.degree. C. for 16 hours, the washing solution was 0.5.times.SSC containing 0.1% SDS and washing was performed twice at 65.degree. C. for 20 minutes. The nucleotide sequence of the hybridized genome clone was determined by the dideoxy method. As a result, a region homologous to the cDNA sequence determined in 6 existed.
The transcription initiation site was determined by the method described in 7. In the vicinity of the transcription initiation site, "TATA" consensus sequence box was observed. The ATG translation initiation site was determined as the upstream most ATG codon in the translation reading frame of the clone and as the ATG codon which is first accessible in the mRNA synthesized in rice.
A part of the DNA sequence of the genome clone hybridized with the cDNA clone is shown in SEQ ID NO. 5. In the genome DNA sequence, a reading frame starting from the ATG translation initiation codon, which overlaps with the corresponding cDNA sequence, was identified. The promoter region is located upstream of the ATG translation initiation codon and starts immediately upstream thereof.
__________________________________________________________________________SEQUENCE LISTING(1) GENERAL INFORMATION:(iii) NUMBER OF SEQUENCES: 7(2) INFORMATION FOR SEQ ID NO:1:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 3040 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: cDNA to mRNA(iii) HYPOTHETICAL: NO(ix) FEATURE:(A) NAME/KEY: CDS(B) LOCATION: 182..2617(xi) SEQUENCE DESCRIPTION: SEQ ID NO:1:AGTCTCTCTTCTCCCGCAATTTTATAATCTCGATCGATCCAATCTGCTCCCCTTCTTCTT60CTACTCTCCCCATCTCGGCTCTCGCCATCGCCATCCTCCTCTCCCTTCCCGGAGAAGACG120CCTCCCTCCGCCGATCACCACCCGGTAGGGCGAGGAGGGAGCCAAATCCAAATCAGCAGC180CATGGCGCAGATGCTGCTCCATGGGACGCTGCACGCCACCATCTTC226MetAlaGlnMetLeuLeuHisGlyThrLeuHisAlaThrIlePhe151015GAGGCGGCGTCGCTCTCCAACCCGCACCGCGCCAGCGGAAGCGCCCCC274GluAlaAlaSerLeuSerAsnProHisArgAlaSerGlySerAlaPro202530AAGTTCATCCGCAAGTTTGTGGAGGGGATTGAGGACACTGTGGGTGTC322LysPheIleArgLysPheValGluGlyIleGluAspThrValGlyVal354045GGCAAAGGCGCCACCAAGGTGTATTCTACCATTGATCTGGAGAAAGCT370GlyLysGlyAlaThrLysValTyrSerThrIleAspLeuGluLysAla505560CGTGTAGGGCGAACTAGGATGATAACCAATGAGCCCATCAACCCTCGC418ArgValGlyArgThrArgMetIleThrAsnGluProIleAsnProArg657075TGGTATGAGTCGTTCCACATCTATTGCGCTCATATGGCTTCCAATGTG466TrpTyrGluSerPheHisIleTyrCysAlaHisMetAlaSerAsnVal80859095ATCTTCACTGTCAAGATTGATAACCCTATTGGGGCAACGAATATTGGG514IlePheThrValLysIleAspAsnProIleGlyAlaThrAsnIleGly100105110AGGGCTTACCTGCCTGTCCAAGAGCTTCTCAATGGAGAGGAGATTGAC562ArgAlaTyrLeuProValGlnGluLeuLeuAsnGlyGluGluIleAsp115120125AGATGGCTCGATATCTGTGATAATAACCGCGAGTCTGTTGGTGAGAGC610ArgTrpLeuAspIleCysAspAsnAsnArgGluSerValGlyGluSer130135140AAGATCCATGTGAAGCTTCAGTACTTCGATGTTTCCAAGGATCGCAAT658LysIleHisValLysLeuGlnTyrPheAspValSerLysAspArgAsn145150155TGGGCGAGGGGTGTCCGCAGTACCAAGTATCCAGGTGTTCCTTACACC706TrpAlaArgGlyValArgSerThrLysTyrProGlyValProTyrThr160165170175TTCTTCTCTCAGAGGCAAGGGTGCAAAGTTACCTTGTACCAAGATGCT754PhePheSerGlnArgGlnGlyCysLysValThrLeuTyrGlnAspAla180185190CATGTCCCAGACAACTTCATTCCAAAGATTCCGCTTGCCGATGGCAAG802HisValProAspAsnPheIleProLysIleProLeuAlaAspGlyLys195200205AATTATGAACCCCACAGATGCTGGGAGGATATCTTTGATGCTATAAGC850AsnTyrGluProHisArgCysTrpGluAspIlePheAspAlaIleSer210215220AATGCTCAACATTTGATTTACATCACTGGCTGGTCTGTATACACTGAG898AsnAlaGlnHisLeuIleTyrIleThrGlyTrpSerValTyrThrGlu225230235ATCACCTTGGTTAGGGACTCCAATCGTCCAAAACCTGGAGGGGATGTC946IleThrLeuValArgAspSerAsnArgProLysProGlyGlyAspVal240245250255ACCCTTGGGGAGTTGCTCAAGAAGAAGGCCAGTGAAGGTGTTCGGGTC994ThrLeuGlyGluLeuLeuLysLysLysAlaSerGluGlyValArgVal260265270CTCATGCTTGTGTGGGATGACAGGACTTCAGTTGGTTTGCTAAAGAGG1042LeuMetLeuValTrpAspAspArgThrSerValGlyLeuLeuLysArg275280285GATGGCTTGATGGCAACACATGATGAGGAAACTGAAAATTACTTCCAT1090AspGlyLeuMetAlaThrHisAspGluGluThrGluAsnTyrPheHis290295300GGCTCTGACGTGAACTGTGTTCTATGCCCTCGCAACCCTGATGACTCA1138GlySerAspValAsnCysValLeuCysProArgAsnProAspAspSer305310315GGCAGCATTGTTCAGGATCTGTCGATCTCAACTATGTTTACACACCAT1186GlySerIleValGlnAspLeuSerIleSerThrMetPheThrHisHis320325330335CAGAAGATAGTAGTTGTTGACCATGAGTTGCCAAACCAGGGCTCCCAA1234GlnLysIleValValValAspHisGluLeuProAsnGlnGlySerGln340345350CAAAGGAGGATAGTCAGTTTCGTTGGTGGCCTTGATCTCTGTGATGGA1282GlnArgArgIleValSerPheValGlyGlyLeuAspLeuCysAspGly355360365AGGTATGACACTCAGTACCATTCTTTGTTTAGGACACTCGACAGTACC1330ArgTyrAspThrGlnTyrHisSerLeuPheArgThrLeuAspSerThr370375380CATCATGATGACTTCCACCAGCCAAACTTTGCCACTGCATCAATCAAA1378HisHisAspAspPheHisGlnProAsnPheAlaThrAlaSerIleLys385390395AAGGGTGGACCTAGAGAGCCATGGCATGATATTCACTCACGGCTGGAA1426LysGlyGlyProArgGluProTrpHisAspIleHisSerArgLeuGlu400405410415GGGCCAATCGCATGGGATGTTCTTTACAATTTCGAGCAGAGATGGAGA1474GlyProIleAlaTrpAspValLeuTyrAsnPheGluGlnArgTrpArg420425430AAGCAGGGTGGTAAGGATCTCCTTCTGCAGCTCAGGGATCTGTCTGAC1522LysGlnGlyGlyLysAspLeuLeuLeuGlnLeuArgAspLeuSerAsp435440445ACTATTATTCCACCTTCTCCTGTTATGTTTCCAGAGGACAGAGAAACA1570ThrIleIleProProSerProValMetPheProGluAspArgGluThr450455460TGGAATGTTCAGCTATTTAGATCCATTGATGGTGGTGCTGCTTTTGGG1618TrpAsnValGlnLeuPheArgSerIleAspGlyGlyAlaAlaPheGly465470475TTCCCTGATACCCCTGAGGAGGCTGCAAAAGCTGGGCTTGTAAGCGGA1666PheProAspThrProGluGluAlaAlaLysAlaGlyLeuValSerGly480485490495AAGGATCAAATCATTGACAGGAGCATCCAGGATGCATACATACATGCC1714LysAspGlnIleIleAspArgSerIleGlnAspAlaTyrIleHisAla500505510ATCCGGAGGGCAAAGAACTTCATCTATATAGAGAACCAATACTTCCTT1762IleArgArgAlaLysAsnPheIleTyrIleGluAsnGlnTyrPheLeu515520525GGAAGTTCCTATGCCTGGAAACCCGAGGGCATCAAGCCTGAAGACATT1810GlySerSerTyrAlaTrpLysProGluGlyIleLysProGluAspIle530535540GGTGCCCTGCATTTGATTCCTAAGGAGCTTGCACTGAAAGTTGTCAGT1858GlyAlaLeuHisLeuIleProLysGluLeuAlaLeuLysValValSer545550555AAGATTGAAGCCGGGGAACGGTTCACTGTTTATGTTGTGGTGCCAATG1906LysIleGluAlaGlyGluArgPheThrValTyrValValValProMet560565570575TGGCCTGAGGGTGTTCCAGAGAGTGGATCTGTTCAGGCAATCCTGGAC1954TrpProGluGlyValProGluSerGlySerValGlnAlaIleLeuAsp580585590TGGCAAAGGAGAACAATGGAGATGATGTACACTGACATTACAGAGGCT2002TrpGlnArgArgThrMetGluMetMetTyrThrAspIleThrGluAla595600605CTCCAAGCCAAGGGAATTGAAGCGAACCCCAAGGACTACCTCACTTTC2050LeuGlnAlaLysGlyIleGluAlaAsnProLysAspTyrLeuThrPhe610615620TTCTGCTTGGGTAACCGTGAGGTGAAGCAGGCTGGGGAATATCAGCCT2098PheCysLeuGlyAsnArgGluValLysGlnAlaGlyGluTyrGlnPro625630635GAAGAACAACCAGAAGCTGACACTGATTACAGCCGAGCTCAGGAAGCT2146GluGluGlnProGluAlaAspThrAspTyrSerArgAlaGlnGluAla640645650655AGGAGGTTCATGATCTATGTCCACACCAAAATGATGATAGTTGACGAT2194ArgArgPheMetIleTyrValHisThrLysMetMetIleValAspAsp660665670GAGTACATCATCATCGGTTCTGCAAACATCAACCAGAGGTCGATGGAC2242GluTyrIleIleIleGlySerAlaAsnIleAsnGlnArgSerMetAsp675680685GGCGCTAGGGACTCTGAGATCGCCATGGGCGGGTACCAGCCATACCAT2290GlyAlaArgAspSerGluIleAlaMetGlyGlyTyrGlnProTyrHis690695700CTGGCGACCAGGCAACCAGCCCGTGGCCAGATCCATGGCTTCCGGATG2338LeuAlaThrArgGlnProAlaArgGlyGlnIleHisGlyPheArgMet705710715GCGCTGTGGTACGAGCACCTGGGAATGCTGGATGATGTGTTCCAGCGC2386AlaLeuTrpTyrGluHisLeuGlyMetLeuAspAspValPheGlnArg720725730735CCCGAGAGCCTGGAGTGTGTGCAGAAGGTGAACAGGATCGCGGAGAAG2434ProGluSerLeuGluCysValGlnLysValAsnArgIleAlaGluLys740745750TACTGGGACATGTACTCCAGCGACGACCTCCAGCAGGACCTCCCTGGC2482TyrTrpAspMetTyrSerSerAspAspLeuGlnGlnAspLeuProGly755760765CACCTCCTCAGCTACCCCATTGGCGTCGCCAGCGATGGTGTGGTGACT2530HisLeuLeuSerTyrProIleGlyValAlaSerAspGlyValValThr770775780GAGCTGCCCGGGATGGAGTACTTTCCTGACACACGGGCCCGCGTCCTC2578GluLeuProGlyMetGluTyrPheProAspThrArgAlaArgValLeu785790795GGCGCCAAGTCGGATTACATGCCCCCCATCCTCACCTCATAGACGAGGA2627GlyAlaLysSerAspTyrMetProProIleLeuThrSer800805810AGCACTACACTACAATCTGCTGGCTTCTCCTGTCAGTCCTTCTGTACTTCTTCAGTTTGG2687TGGCGAGATGGTATGGCCGTTGTTCAGAATTTCTTCAGAATAGCAGTTGTTACAGTTGTG2747AATCATAAAGTAATAAGTGCAGTATCTGTGCATGGTTGAGTTGGGAAGAAGATCGGGGAT2807GCAATGATGCTTGTGAAGTTGTGATGCCGTTTGTAAGATGGGAAGTTGGGAACTACTAAG2867TAATTGGCATGATTGTACTTTGCACTACTGTTTAGCGTTGTTGATACTGGTTAACCGTGT2927GTTCATCTGAACTTGATTCTTGATGCAGTTTGTGGCATTACCAGTTTATCATCGTTCTTC2987AGGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA3040(2) INFORMATION FOR SEQ ID NO:2:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 812 amino acids(B) TYPE: amino acid(D) TOPOLOGY: linear(ii) MOLECULE TYPE: protein(xi) SEQUENCE DESCRIPTION: SEQ ID NO:2:MetAlaGlnMetLeuLeuHisGlyThrLeuHisAlaThrIlePheGlu151015AlaAlaSerLeuSerAsnProHisArgAlaSerGlySerAlaProLys202530PheIleArgLysPheValGluGlyIleGluAspThrValGlyValGly354045LysGlyAlaThrLysValTyrSerThrIleAspLeuGluLysAlaArg505560ValGlyArgThrArgMetIleThrAsnGluProIleAsnProArgTrp65707580TyrGluSerPheHisIleTyrCysAlaHisMetAlaSerAsnValIle859095PheThrValLysIleAspAsnProIleGlyAlaThrAsnIleGlyArg100105110AlaTyrLeuProValGlnGluLeuLeuAsnGlyGluGluIleAspArg115120125TrpLeuAspIleCysAspAsnAsnArgGluSerValGlyGluSerLys130135140IleHisValLysLeuGlnTyrPheAspValSerLysAspArgAsnTrp145150155160AlaArgGlyValArgSerThrLysTyrProGlyValProTyrThrPhe165170175PheSerGlnArgGlnGlyCysLysValThrLeuTyrGlnAspAlaHis180185190ValProAspAsnPheIleProLysIleProLeuAlaAspGlyLysAsn195200205TyrGluProHisArgCysTrpGluAspIlePheAspAlaIleSerAsn210215220AlaGlnHisLeuIleTyrIleThrGlyTrpSerValTyrThrGluIle225230235240ThrLeuValArgAspSerAsnArgProLysProGlyGlyAspValThr245250255LeuGlyGluLeuLeuLysLysLysAlaSerGluGlyValArgValLeu260265270MetLeuValTrpAspAspArgThrSerValGlyLeuLeuLysArgAsp275280285GlyLeuMetAlaThrHisAspGluGluThrGluAsnTyrPheHisGly290295300SerAspValAsnCysValLeuCysProArgAsnProAspAspSerGly305310315320SerIleValGlnAspLeuSerIleSerThrMetPheThrHisHisGln325330335LysIleValValValAspHisGluLeuProAsnGlnGlySerGlnGln340345350ArgArgIleValSerPheValGlyGlyLeuAspLeuCysAspGlyArg355360365TyrAspThrGlnTyrHisSerLeuPheArgThrLeuAspSerThrHis370375380HisAspAspPheHisGlnProAsnPheAlaThrAlaSerIleLysLys385390395400GlyGlyProArgGluProTrpHisAspIleHisSerArgLeuGluGly405410415ProIleAlaTrpAspValLeuTyrAsnPheGluGlnArgTrpArgLys420425430GlnGlyGlyLysAspLeuLeuLeuGlnLeuArgAspLeuSerAspThr435440445IleIleProProSerProValMetPheProGluAspArgGluThrTrp450455460AsnValGlnLeuPheArgSerIleAspGlyGlyAlaAlaPheGlyPhe465470475480ProAspThrProGluGluAlaAlaLysAlaGlyLeuValSerGlyLys485490495AspGlnIleIleAspArgSerIleGlnAspAlaTyrIleHisAlaIle500505510ArgArgAlaLysAsnPheIleTyrIleGluAsnGlnTyrPheLeuGly515520525SerSerTyrAlaTrpLysProGluGlyIleLysProGluAspIleGly530535540AlaLeuHisLeuIleProLysGluLeuAlaLeuLysValValSerLys545550555560IleGluAlaGlyGluArgPheThrValTyrValValValProMetTrp565570575ProGluGlyValProGluSerGlySerValGlnAlaIleLeuAspTrp580585590GlnArgArgThrMetGluMetMetTyrThrAspIleThrGluAlaLeu595600605GlnAlaLysGlyIleGluAlaAsnProLysAspTyrLeuThrPhePhe610615620CysLeuGlyAsnArgGluValLysGlnAlaGlyGluTyrGlnProGlu625630635640GluGlnProGluAlaAspThrAspTyrSerArgAlaGlnGluAlaArg645650655ArgPheMetIleTyrValHisThrLysMetMetIleValAspAspGlu660665670TyrIleIleIleGlySerAlaAsnIleAsnGlnArgSerMetAspGly675680685AlaArgAspSerGluIleAlaMetGlyGlyTyrGlnProTyrHisLeu690695700AlaThrArgGlnProAlaArgGlyGlnIleHisGlyPheArgMetAla705710715720LeuTrpTyrGluHisLeuGlyMetLeuAspAspValPheGlnArgPro725730735GluSerLeuGluCysValGlnLysValAsnArgIleAlaGluLysTyr740745750TrpAspMetTyrSerSerAspAspLeuGlnGlnAspLeuProGlyHis755760765LeuLeuSerTyrProIleGlyValAlaSerAspGlyValValThrGlu770775780LeuProGlyMetGluTyrPheProAspThrArgAlaArgValLeuGly785790795800AlaLysSerAspTyrMetProProIleLeuThrSer805810(2) INFORMATION FOR SEQ ID NO:3:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 2804 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: cDNA to mRNA(iii) HYPOTHETICAL: NO(ix) FEATURE:(A) NAME/KEY: CDS(B) LOCATION: 107..2542(xi) SEQUENCE DESCRIPTION: SEQ ID NO:3:ATCACCGTCGTCATCAATCACGGTGACCTTGCCCTCGCTGCCCGACTGGAACCGGACGCT60GCTGCTGCTGGTAGGCTGACAGCGAGGAGGACGAGACGAGGGGGCCATGGCTCAG115MetAlaGln815ATCTTGCTCCACGGCACGCTCCACGCCACCATCTTCGAGGCCGAGTCG163IleLeuLeuHisGlyThrLeuHisAlaThrIlePheGluAlaGluSer820825830CTCTCCAACCCGCACCGCGCCACTGGCGGCGCCCCCAAGTTCATCCGC211LeuSerAsnProHisArgAlaThrGlyGlyAlaProLysPheIleArg835840845AAGCTTGTGGAAGGGATCGAGGACACCGTGGGTGTCGGCAAGGGCGCC259LysLeuValGluGlyIleGluAspThrValGlyValGlyLysGlyAla850855860ACCAAGATATATGCCACCGTCGATCTCGAGAAGGCCCGTGTCGGGCGG307ThrLysIleTyrAlaThrValAspLeuGluLysAlaArgValGlyArg865870875ACCCGGATGATCTCCAACGAGCCCGTGAACCCTCGTTGGTACGAGTCC355ThrArgMetIleSerAsnGluProValAsnProArgTrpTyrGluSer880885890895TTCCACATCTACTGCGCGCACATGGCCGCCGACGTCATCTTCACCGTC403PheHisIleTyrCysAlaHisMetAlaAlaAspValIlePheThrVal900905910AAGATCGACAACTCCATCGGGGCCTCGCTCATCGGGAGGGCCTACTTG451LysIleAspAsnSerIleGlyAlaSerLeuIleGlyArgAlaTyrLeu915920925GCTGTCCAGGACCTCCTGGGAGGGGAGGAGATCGACAAGTGGCTTGAA499AlaValGlnAspLeuLeuGlyGlyGluGluIleAspLysTrpLeuGlu930935940ATCTCCGATGAAAATCGTGAGCCTGTTGGGGACAGCAAGATCCATGTG547IleSerAspGluAsnArgGluProValGlyAspSerLysIleHisVal945950955AAGCTCCAGTACTTTGACGTCGGCAAGGACCGTAACTGGGCGAGGGGT595LysLeuGlnTyrPheAspValGlyLysAspArgAsnTrpAlaArgGly960965970975GTCCGGAGCACCAAGTACCCTGGTGTCCCTTACACCTTCTTCTCGCAG643ValArgSerThrLysTyrProGlyValProTyrThrPhePheSerGln980985990AGGCAGGGGTGTAAGGTTACTCTGTACCAGGACGCTCATGTGCCGGAC691ArgGlnGlyCysLysValThrLeuTyrGlnAspAlaHisValProAsp99510001005AACTTTGTTCCCAGGATCCAGCTCGCTGATGGCAAGAACTATGAGCCG739AsnPheValProArgIleGlnLeuAlaAspGlyLysAsnTyrGluPro101010151020CACAGGTGCTGGGAGGATATCTTTGATGCTATAAGCAAGGCTCAGCAT787HisArgCysTrpGluAspIlePheAspAlaIleSerLysAlaGlnHis102510301035TTGATTTACATCACTGGCTGGTCCGTGTACACAGAGATCACCTTGGTC835LeuIleTyrIleThrGlyTrpSerValTyrThrGluIleThrLeuVal1040104510501055AGGGACACCAACAGGCCAAAACCTGGTGGTGATGTTACTCTTGGGGAG883ArgAspThrAsnArgProLysProGlyGlyAspValThrLeuGlyGlu106010651070TTGCTCAAGAGGAAGGCCAGTGAAGGTGTCCGGGTGCTTATGCTGGTG931LeuLeuLysArgLysAlaSerGluGlyValArgValLeuMetLeuVal107510801085TGGGATGACAGGACTTCTGTCGGCCTGCTTAAGAAGGATGGCTTGATG979TrpAspAspArgThrSerValGlyLeuLeuLysLysAspGlyLeuMet109010951100GCTACCCATGATGAGGAGACTGCAAATTACTTCCATGGCACGGATGTC1027AlaThrHisAspGluGluThrAlaAsnTyrPheHisGlyThrAspVal110511101115AACTGTGTTCTGTGCCCTCGCAACCCTGATGATTCTGGCAGCTTTGTC1075AsnCysValLeuCysProArgAsnProAspAspSerGlySerPheVal1120112511301135CAGGATCTGCAGATATCAACTATGTTCACGCACCACCAGAAGATAGTA1123GlnAspLeuGlnIleSerThrMetPheThrHisHisGlnLysIleVal114011451150GTAGTCGACCATGAGATGCCGAACCAGGGATCCCAGCAAAGGAGGATA1171ValValAspHisGluMetProAsnGlnGlySerGlnGlnArgArgIle115511601165GTCAGCTTCATTGGTGGCATTGACCTTTGTGATGGAAGATATGATACC1219ValSerPheIleGlyGlyIleAspLeuCysAspGlyArgTyrAspThr117011751180CAGTACCACTCCTTGTTCAGGACGCTTGACACTGTCCATCACGATGAC1267GlnTyrHisSerLeuPheArgThrLeuAspThrValHisHisAspAsp118511901195TTCCACCAGCCGAACTTTGAGGGTGGGTCAATCAAGAAAGGTGGCCCA1315PheHisGlnProAsnPheGluGlyGlySerIleLysLysGlyGlyPro1200120512101215AGGGAGCCATGGCATGATATCCACTCACGGTTGGAAGGGCCAATCGCT1363ArgGluProTrpHisAspIleHisSerArgLeuGluGlyProIleAla122012251230TGGGATGTTCTTTACAACTTTGAGCAGAGATGGAGAAAGCAGGGTGGT1411TrpAspValLeuTyrAsnPheGluGlnArgTrpArgLysGlnGlyGly123512401245AAGGACCTCCTTGTGCGTCTCAGGGATCTTCCTGACATTATCATCCCC1459LysAspLeuLeuValArgLeuArgAspLeuProAspIleIleIlePro125012551260CCTTCTCCTGTGATGTTCCCGGAGGACAGAGAGACATGGAATGTTCAG1507ProSerProValMetPheProGluAspArgGluThrTrpAsnValGln126512701275CTCTTCAGATCCATCGATGGTGGTGCTGCTTTTGGCTTCCCCGAGACT1555LeuPheArgSerIleAspGlyGlyAlaAlaPheGlyPheProGluThr1280128512901295CCCGAGGAAGCTGCAAGAGCTGGGCTTGTGAGTGGAAAGGATCAAATC1603ProGluGluAlaAlaArgAlaGlyLeuValSerGlyLysAspGlnIle130013051310ATCGACCGGAGTATCCAGGATGCATACGTAAACGCCATACGGAGGGCG1651IleAspArgSerIleGlnAspAlaTyrValAsnAlaIleArgArgAla131513201325AAGAACTTCATCTACATTGAGAATCAGTACTTCCTTGGAAGTTCATAC1699LysAsnPheIleTyrIleGluAsnGlnTyrPheLeuGlySerSerTyr133013351340GGCTGGAAGCCCGAAGGCATCAAGCCGGAAGAAATCGGTGCTCTTCAC1747GlyTrpLysProGluGlyIleLysProGluGluIleGlyAlaLeuHis134513501355TTGATTCCGAAGGAGCTCTCGCTGAAGATTGTCAGCAAGATTGAAGCT1795LeuIleProLysGluLeuSerLeuLysIleValSerLysIleGluAla1360136513701375GGGGAGCGGTTTACTGTTTATGTTGTGGTGCCAATGTGGCCTGAGGGT1843GlyGluArgPheThrValTyrValValValProMetTrpProGluGly138013851390GTTCCAGAAAGCGCTTCTGTTCAGGCAATCCTTGACTGGCAAAGGAGA1891ValProGluSerAlaSerValGlnAlaIleLeuAspTrpGlnArgArg139514001405ACGATGGAGATGATGTACACTGACATCGCACAAGCTCTCGAAGCCAAC1939ThrMetGluMetMetTyrThrAspIleAlaGlnAlaLeuGluAlaAsn141014151420GGGATTGAAGCAAACCCCAAGGACTATCTCACTTTCTTCTGCTTAGGT1987GlyIleGluAlaAsnProLysAspTyrLeuThrPhePheCysLeuGly142514301435AACCGTGAGGTAAAGCAGGAGGGAGAATATGAACCAGAGGAGCACCCA2035AsnArgGluValLysGlnGluGlyGluTyrGluProGluGluHisPro1440144514501455GAACCTGACACTGATTACATCCGGGCTCAAGAGGCTAGGAGGTTTATG2083GluProAspThrAspTyrIleArgAlaGlnGluAlaArgArgPheMet146014651470ATCTATGTTCATACCAAAATGATGATAGTGGACGACGAGTACATCATC2131IleTyrValHisThrLysMetMetIleValAspAspGluTyrIleIle147514801485ATTGGGTCCGCCAACATCAACCAGAGGTCCATGGACGGTGCCAGGGAC2179IleGlySerAlaAsnIleAsnGlnArgSerMetAspGlyAlaArgAsp149014951500TCCGAGATCGCCATGGGCGCGTACCAGCCGTACCACTTGGCGACTAGG2227SerGluIleAlaMetGlyAlaTyrGlnProTyrHisLeuAlaThrArg150515101515CAGCCTGCCCGGGGCCAGATCCATGGCTTCCGGATGTCTCTTTGGTAC2275GlnProAlaArgGlyGlnIleHisGlyPheArgMetSerLeuTrpTyr1520152515301535GAGCACCTGGGAATGCTGGAAGACGTCTTCCAGCGGCCCGAGAGCGTA2323GluHisLeuGlyMetLeuGluAspValPheGlnArgProGluSerVal154015451550GAGTGTGTGCAGAAGGTGAACGAGGTCGCCGAGAAGTACTGGGACCTG2371GluCysValGlnLysValAsnGluValAlaGluLysTyrTrpAspLeu155515601565TACTCGAGCGACGACCTGGAGCAGGACCTCCCGGGCCACCTCCTCAGC2419TyrSerSerAspAspLeuGluGlnAspLeuProGlyHisLeuLeuSer157015751580TACCCGATCGGTGTCACTGCCGACGGCAGCGTTACCGAGCTGCCCGGG2467TyrProIleGlyValThrAlaAspGlySerValThrGluLeuProGly158515901595ATGGAGAACTTCCCCGACACCCGCGCCCGCGTCCTCGGGAACAAGTCG2515MetGluAsnPheProAspThrArgAlaArgValLeuGlyAsnLysSer1600160516101615GATTACCTCCCGCCCATCCTCACCACATAGAGTGCACACTGCAGGCA2562AspTyrLeuProProIleLeuThrThr1620GCGCCATGGCTGCTCTCCTCTCTGGCCTCACCTTGGTGTCCCTGTGTTTGTGTTTGGGAC2622ACTGGAGGTTCAGATTGCAGTGTTGATATTATATCCCCCCTCCGTCCAGAGGGATTCGAC2682GTTATTGAGTCATAATAAAATGCATTGTGCACGGTGGGAGACTGGGAGGATAGGAATTAT2742AGTTGTTTATTACAGTACGACTGCTTACTGCATCCAGATTGTGTTGTCCCTAAAAAAAAA2802AA2804(2) INFORMATION FOR SEQ ID NO:4:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 812 amino acids(B) TYPE: amino acid(D) TOPOLOGY: linear(ii) MOLECULE TYPE: protein(xi) SEQUENCE DESCRIPTION: SEQ ID NO:4:MetAlaGlnIleLeuLeuHisGlyThrLeuHisAlaThrIlePheGlu151015AlaGluSerLeuSerAsnProHisArgAlaThrGlyGlyAlaProLys202530PheIleArgLysLeuValGluGlyIleGluAspThrValGlyValGly354045LysGlyAlaThrLysIleTyrAlaThrValAspLeuGluLysAlaArg505560ValGlyArgThrArgMetIleSerAsnGluProValAsnProArgTrp65707580TyrGluSerPheHisIleTyrCysAlaHisMetAlaAlaAspValIle859095PheThrValLysIleAspAsnSerIleGlyAlaSerLeuIleGlyArg100105110AlaTyrLeuAlaValGlnAspLeuLeuGlyGlyGluGluIleAspLys115120125TrpLeuGluIleSerAspGluAsnArgGluProValGlyAspSerLys130135140IleHisValLysLeuGlnTyrPheAspValGlyLysAspArgAsnTrp145150155160AlaArgGlyValArgSerThrLysTyrProGlyValProTyrThrPhe165170175PheSerGlnArgGlnGlyCysLysValThrLeuTyrGlnAspAlaHis180185190ValProAspAsnPheValProArgIleGlnLeuAlaAspGlyLysAsn195200205TyrGluProHisArgCysTrpGluAspIlePheAspAlaIleSerLys210215220AlaGlnHisLeuIleTyrIleThrGlyTrpSerValTyrThrGluIle225230235240ThrLeuValArgAspThrAsnArgProLysProGlyGlyAspValThr245250255LeuGlyGluLeuLeuLysArgLysAlaSerGluGlyValArgValLeu260265270MetLeuValTrpAspAspArgThrSerValGlyLeuLeuLysLysAsp275280285GlyLeuMetAlaThrHisAspGluGluThrAlaAsnTyrPheHisGly290295300ThrAspValAsnCysValLeuCysProArgAsnProAspAspSerGly305310315320SerPheValGlnAspLeuGlnIleSerThrMetPheThrHisHisGln325330335LysIleValValValAspHisGluMetProAsnGlnGlySerGlnGln340345350ArgArgIleValSerPheIleGlyGlyIleAspLeuCysAspGlyArg355360365TyrAspThrGlnTyrHisSerLeuPheArgThrLeuAspThrValHis370375380HisAspAspPheHisGlnProAsnPheGluGlyGlySerIleLysLys385390395400GlyGlyProArgGluProTrpHisAspIleHisSerArgLeuGluGly405410415ProIleAlaTrpAspValLeuTyrAsnPheGluGlnArgTrpArgLys420425430GlnGlyGlyLysAspLeuLeuValArgLeuArgAspLeuProAspIle435440445IleIleProProSerProValMetPheProGluAspArgGluThrTrp450455460AsnValGlnLeuPheArgSerIleAspGlyGlyAlaAlaPheGlyPhe465470475480ProGluThrProGluGluAlaAlaArgAlaGlyLeuValSerGlyLys485490495AspGlnIleIleAspArgSerIleGlnAspAlaTyrValAsnAlaIle500505510ArgArgAlaLysAsnPheIleTyrIleGluAsnGlnTyrPheLeuGly515520525SerSerTyrGlyTrpLysProGluGlyIleLysProGluGluIleGly530535540AlaLeuHisLeuIleProLysGluLeuSerLeuLysIleValSerLys545550555560IleGluAlaGlyGluArgPheThrValTyrValValValProMetTrp565570575ProGluGlyValProGluSerAlaSerValGlnAlaIleLeuAspTrp580585590GlnArgArgThrMetGluMetMetTyrThrAspIleAlaGlnAlaLeu595600605GluAlaAsnGlyIleGluAlaAsnProLysAspTyrLeuThrPhePhe610615620CysLeuGlyAsnArgGluValLysGlnGluGlyGluTyrGluProGlu625630635640GluHisProGluProAspThrAspTyrIleArgAlaGlnGluAlaArg645650655ArgPheMetIleTyrValHisThrLysMetMetIleValAspAspGlu660665670TyrIleIleIleGlySerAlaAsnIleAsnGlnArgSerMetAspGly675680685AlaArgAspSerGluIleAlaMetGlyAlaTyrGlnProTyrHisLeu690695700AlaThrArgGlnProAlaArgGlyGlnIleHisGlyPheArgMetSer705710715720LeuTrpTyrGluHisLeuGlyMetLeuGluAspValPheGlnArgPro725730735GluSerValGluCysValGlnLysValAsnGluValAlaGluLysTyr740745750TrpAspLeuTyrSerSerAspAspLeuGluGlnAspLeuProGlyHis755760765LeuLeuSerTyrProIleGlyValThrAlaAspGlySerValThrGlu770775780LeuProGlyMetGluAsnPheProAspThrArgAlaArgValLeuGly785790795800AsnLysSerAspTyrLeuProProIleLeuThrThr805810(2) INFORMATION FOR SEQ ID NO:5:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 2799 base pairs(B) TYPE: nucleic acid(C) STRANDEDNESS: single(D) TOPOLOGY: linear(ii) MOLECULE TYPE: DNA (genomic)(ix) FEATURE:(A) NAME/KEY: CDS(B) LOCATION: 1876..1983(ix) FEATURE:(A) NAME/KEY: CDS(B) LOCATION: 2524..2799(xi) SEQUENCE DESCRIPTION: SEQ ID NO:5:CAAGGGTGTACATAGATTTGTCTCGTAAAATAGTATTATAATATTATAAACTTATTACTC60TATCCGTTCTAAAATATAAGAACCTTATGACTGGATGGAACATTTCCTAGTACTACGAAT120CTGAACACATGTCTAGATTCATAGTACTAGGAAATGTCTCATCGCGGTACTAGGTTCTTA180TATTTTAGGATGGAGGGAGTTTAATATAAAACTAATGGTTAGAACTTTGAAAGTTTGATT240TTAAATGTCAAATATTTATGGCTGGAGGTAGTATAATATGTTTTTTTTGGGACGTAGACT300AGGTAGTATAATATGTTTGGTTGTGTTTAGATCCAATATTTGGATCCAAACTTCAGTCAT360TTTCCATCACATCAACTTGTCATATACACATAACTTTTCAGTCACATCATCCCCAATTTC420AACCAAAATCAAACTTTGCGCTGAACTAAACACAACCTTTGGGCCCGTTTAGTTCCCCAA480TTTTTTTCCCAAAAACATCACATCGAATCTTTGGACACATGCATGAAGCATTAAATATAG540ATAAAAAGAAAAACTAATTGCACAGTTATGGAGGAAATCGCGAGACGAATCTTTTAAGCC600TAATTAGTCCGTGATTAGCCATAAGTGCTACAGTAACCCAATTGTGCTAATGACGGCTTA660ATTAGTCTCCACAAGATTCGTCTCGCAGTTTCCAGGCGAGTTCTGAAATTAGTTTTTTCA720TTCGTGTCCGAAAACCCCTTCCGACATCCGGTCAAACGTTCGATATGACACCCACAAATT780TTCTTTTCCCCAACTAAACACACCCTTTATCTCTTACCCTCTGGCTCTTTCAGTAGGCAT840ATCCAAGACAGCTGGTAATGCAGGCTCGGACATAATTTGACAGTTACGTTCATGTGACCG900ACGGTTGATGCTAGTGCAACTGCAACATACTGTTCAGATGGATGTCCCAACGAGCTCAAA960ACAACTTAGGTGGCGCGTCGCGATTCATCAATAACTCAAATGGAAGCGCAAGTGCACGTA1020CGAAAATGACAGCGAGTGAGGTGGCGAGCCTCACCTTGGTGATCCCAACCGGATAAGCTA1080TGCATCAGCCAGTTTCGTGGGGCTGCACATTTCGTCGAACACCTGGAGTCCACGCCGCCG1140GCGACGTCGGCACAGCGCGCCCGCCCACCGCCCACGCACGCGCTTGACTCCACCCATGTT1200CTCCCTTCTCGACGCCCGCGAAGCCAGCGAACCGATCCGAGGAAGTCAAGCCCCCACCGC1260CACTTGGACCGACCTCGGGACGACGACGCCCCCGCGCTCTTCTAGACGCGCGGACGACGC1320GGGCGCTGGCTCCGCGACGCGACGTCGCGGTCATGGAGTAACCGCGACGGACAGATACTT1380CTACCCGTTTTTAACCTCGCCTCCTCCTCCTCCCGGCTCGAGATCCGTGGCCACGACGCG1440TGGTGGGAAACCGGGAACGACGTGCACGCACGCACACAGGGCAAGTTTCAGTAGAAAAAT1500CGCCGGCATCCAGATCGGGACAGTCTCTCTTCTCCCGCAATTTTATAATCTCGCTCGATC1560CAATCTGCTCCCCTTCTTCTTCTACTCTCCCCATCTCGGCTCTCGCCATCGCCATCCTCC1620TCTCCCTTCCCGGAGAAGACGCCTCCCTCCGCCGATCACCACCCGGTAAGCCCAGTGTGC1680TTAGGCTAAGCGCACTAGAGCTTCTTGCTCGCTTGCTTCTTCTCCGCTCAGATCTGCTTG1740CTTGCTTGCTTCGCTAGAACCCTACTCTGTGCTGCGAGTGTCGCTGCTTCGTCTTCCTTC1800CTCAAGTTCGATCTGATTGTGTGTGTGGGGGGGCGCAGGTAGGGCGAGGAGGGAGCCAAA1860TCCAAATCAGCAGCCATGGCGCAGATGCTGCTCCATGGGACGCTGCACGCC1911MetAlaGlnMetLeuLeuHisGlyThrLeuHisAla815820ACCATCTTCGAGGCGGCGTCGCTCTCCAACCCGCACCGCGCCAGCGGA1959ThrIlePheGluAlaAlaSerLeuSerAsnProHisArgAlaSerGly825830835840AGCGCCCCCAAGTTCATCCGCAAGGTTCGGACCCTTCTCCTTAATCTACTCGTC2013SerAlaProLysPheIleArgLys845TTTGCTCTTGCTCTTTTTCTTTTGTGTCCCTTTCTTGTGTGTGCGTTTGCATGAGCCCGA2073ATTTGATCTGCTAGTGCACAGTACAGTCAGATACACTGAAACGATCTGGAAATTCTGGAT2133TATTAGGAAAAATAAAGAGGTAGTAGACAAGAATTGGAGATACTTTCTATCAAGATTGGT2193CTATTATGCTTGGCCATTTCTTGTTTGACCCAAGTACTTCTTTGAATCTAGAGTTTGCTG2253TGTGTGATGTGGTGTGTGTTTGTGTCACCAAAAATCTTCATTAGCTAAAACTGAAATTTT2313ATTTATTAACTGACCTACTAAAAATGTAGAGTTCTCTGTGTGTGATGTGTGCTTGTGTCA2373CCAAAAATCTTGATTTGATAGAGTTTTTATTTATTTATTAACTGACCTACTACAAATCTA2433TTGCTGTATGCTATGTGTGTCTGTATCACCTGAAATGCAATGTCTTCTTCTTTGTTGTTC2493TTGATCTAACACGTGAGCTCATGTCAACAGTTTGTGGAGGGGATTGAGGACACT2547PheValGluGlyIleGluAspThr15GTGGGTGTCGGCAAAGGCGCCACCAAGGTGTATTCTACCATTGATCTG2595ValGlyValGlyLysGlyAlaThrLysValTyrSerThrIleAspLeu101520GAGAAAGCTCGTGTAGGGCGAACTAGGATGATAACCAATGAGCCCATC2643GluLysAlaArgValGlyArgThrArgMetIleThrAsnGluProIle25303540AACCCTCGCTGGTATGAGTCGTTCCACATCTATTGCGCTCATATGGCT2691AsnProArgTrpTyrGluSerPheHisIleTyrCysAlaHisMetAla455055TCCAATGTGATCTTCACTGTCAAGATTGATAACCCTATTGGGGCAACG2739SerAsnValIlePheThrValLysIleAspAsnProIleGlyAlaThr606570AATATTGGGAGGGCTTACCTGCCTGTCCAAGAGCTTCTCAATGGAGAG2787AsnIleGlyArgAlaTyrLeuProValGlnGluLeuLeuAsnGlyGlu758085GAGATTGACAGA2799GluIleAspArg90(2) INFORMATION FOR SEQ ID NO:6:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 36 amino acids(B) TYPE: amino acid(D) TOPOLOGY: linear(ii) MOLECULE TYPE: protein(xi) SEQUENCE DESCRIPTION: SEQ ID NO:6:MetAlaGlnMetLeuLeuHisGlyThrLeuHisAlaThrIlePheGlu151015AlaAlaSerLeuSerAsnProHisArgAlaSerGlySerAlaProLys202530PheIleArgLys35(2) INFORMATION FOR SEQ ID NO:7:(i) SEQUENCE CHARACTERISTICS:(A) LENGTH: 92 amino acids(B) TYPE: amino acid(D) TOPOLOGY: linear(ii) MOLECULE TYPE: protein(xi) SEQUENCE DESCRIPTION: SEQ ID NO:7:PheValGluGlyIleGluAspThrValGlyValGlyLysGlyAlaThr151015LysValTyrSerThrIleAspLeuGluLysAlaArgValGlyArgThr202530ArgMetIleThrAsnGluProIleAsnProArgTrpTyrGluSerPhe354045HisIleTyrCysAlaHisMetAlaSerAsnValIlePheThrValLys505560IleAspAsnProIleGlyAlaThrAsnIleGlyArgAlaTyrLeuPro65707580ValGlnGluLeuLeuAsnGlyGluGluIleAspArg8590__________________________________________________________________________

Number	Date	Country
504869	Sep 1992	EPX
3-187382	Aug 1991	JPX
04222527	Aug 1992	JPX
5-76357	Mar 1993	JPX
WO9400977	Jan 1994	WOX

Phospholipase D gene originated from plant

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

US Classifications

Field of Search

US

International Classifications

Abstract

Description

Claims

Priority Claims (1)

PCT Information

Foreign Referenced Citations (5)

Non-Patent Literature Citations (15)

Entry
Hayashi et al, Derwent WPI, EP 504869 (Sep. 23, 1992).
Derwent WPI, JP 04222527 (Aug. 12, 1992).
Wang et al. (1944). J. Biol. Chem. 269(32): 20312-20317 Aug. 12, 1994.
Takano et al, J. Jpn. Soc. Food Sci. Technol., vol. 34, No. 1, pp. 8-13 (1987).
Lee, Plant Science, vol. 59, pp. 25-33 (1989).
Brauer et al, Plant Physiol., vol. 92, pp. 672-678 (1990).
Abousalham et al, Biochimica et Biophysica Acta, vol. 1158, pp. 1-7 (1993).
Annual Mtg. of the American Society of Plant Physiologists, Pittsburgh, PA, Aug. 1-5, 1992, Abstract 447.
J. Biochem. 83, 677-680 (1978).
The Journal of Biological Chemistry, vol. 252, No. 3 pp. 1102-1106, 1977.
Plant Science, 59 (1989) 25-33.
Biochimica et Biophysica Acta, 369 (1974) 397-410.
Nippon Shokuhin Kogyo Gakkaishi vol. 34, No. 1, 8-13 (1987).
Journal of Bacteriology, Mar. 1990, pp. 1256-1261, vol. 172, No. 3.
Lambrecht, Romy and Ulbrich-Hofmann, Renate. Fachbereich Biochemie/Biotechnologie, Institut fur Biochemie, vol. 373 (1992).